Furthermore, the combination of 5-AZA with trans-retinoic acid (ATRA) restores the NR2F1-induced dormant program and induces TGF-β2, thereby inhibiting cancer metastasis by restoring the TGF-β-SMAD4 signaling [176]. The gene discussed is TGFB2; the disease is cancer.